Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors

• 收藏
• 分享

专利权人:

Axikin Pharmaceuticals; Inc.

发明人:

Ly, Tai Wei,Raaum, Erik Dean

申请号：

AU2014324132

公开号：

AU2014324132A1

申请日:

2014.09.17

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

Provided herein are pharmaceutically acceptable salts of 3,5-diaminopyrazoles, for example, pharmaceutically acceptable salts of compounds of Formula (IA), that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/